A group of molecules in prostate-cancer cells have been identified that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels indicate their cancer has recurred after surgical removal of the prostate.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1FZoddj
from Today's Healthcare News -- ScienceDaily http://ift.tt/1FZoddj
No comments:
Post a Comment